Arabic Arabic English English French French German German
dark

Stem cell therapy company Amniotics raises SEK 60 million before deduction of transaction costs, in First North IPO to advance lead candidate PulmoStem™ into clinic

Amniotics AB, a stem cell therapy company has raised SEK60 million through its recent listing on Nasdaq First North Growth Market. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

Next Post

Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning

Related Posts
Total
0
Share